Safety, tolerabilityand efficacy of lecozotan sr in patients with mild-tomoderate Alzheimer's disease used as monotherapy or adjunctively with a cholinesterase inhibitor

Authors
Category Primary study
JournalAlzheimer's and Dementia
Year 2012
This article has no abstract
Epistemonikos ID: 64a7d580cdbdb1430dd004de4b10315635319147
First added on: Feb 05, 2025